- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03032861
The Prebiotic Effect of Daily Intake of Orange Juice Affects the Bioavailability of Flavanones?
April 25, 2017 updated by: Thais Cesar, São Paulo State University
Influence of the Prebiotic Effect of Orange Juice on the Bioavailability of Flavanones After Chronic Intake of Orange Juice.
This study aimed investigate the chronic effect of orange juice consumption on gut microbiota and in the bioavailability of flavanones and metabolites by feces, blood and urine analysis.
Study Overview
Detailed Description
Non-randomized study with interrupted time series and open-label, in which women were enrolled and advised to not consumed foods containing prebiotic, probiotic and fibers, and citrus fruits and beverages during 30 days before of intervention (n=10; BMI 23.8 kg/m2; 28 years).
After 30 days, the participants will consume during 60 days 300 mL of orange juice daily.
After 60 days of orange juice intervention, the participants will be submitted to 30 days of washout.
Samples of blood, urine and feces will collect in five different occasions (baseline, 30 day, 60 day, 90 day, and 120 day) in order to evaluate the prebiotic effect of orange juice on gut microbiota and in the bioavailability of its flavanones.
The recruitment process began in September 2016 and the intervention was carried out from October 2016 to February 2017, and the data analysis will start in February 2017.
The sample number took into account variances on blood hesperitin levels with a type I error α = 0.05 and a type II error β = 0.2 (80% power) (Silveira et al., 2015).
The minimum sample size should have six individuals into the same group.
Considering an approximately 15% dropout rate, the final sample size of study was constituted by 10 women.
Primary endpoint is the changes in total bacteria population (Lactobacillus spp., Bifidobacterium spp., and reduction of Clostridium spp.) that can result in increased of butyric, acetic, and propionic acid concentrations, and reduction of ammonium production.
Secondary endpoint is enhancement of bioavailability of flavanones (hesperitin, naringenin) and metabolites in the blood, urine and feces.
Kolmogorov Smirnov and Levene test will be used to assess the normality and homogeneity of data, respectively.
One-way analysis of variance (ANOVA) will be apply to determine the intervention effect over the time 0, 30 day, 60 day, 90 day, and 120 day).
P significance was set up ≤ 0.05.
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Sao Paulo
-
Araraquara, Sao Paulo, Brazil, 14800-903
- Sao Paulo State University "Julio de Mesquita Filho", Faculdade de Ciências Farmacêuticas
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 55 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
Healthy women BMI 18.5 - 29.9 kg/m2.
Exclusion Criteria:
Gastrointestinal diseases Pregnant women Regular use of medications Dietary restrictions, vegetarian diet, macrobiotic, etc. Use of vitamins or dietary supplements Use of probiotics or prebiotics in the last 3 months and antibiotics in the last 6 months.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Orange juice
Ten women will consume 100% orange juice (300 mL/day) during 60 days.
|
Thirty days before the beginning of trial, women (n= 10; BMI 23.8 kg/m2; 28 years) will be advised to not consumed foods containing prebiotic, probiotic and fibers, and citrus fruits and beverages.
After 30 days, the participants will consume 300 mL of orange juice daily during 60 days.
After 60 days of orange juice intervention, the participants will be submitted to 30 days of washout.
Samples of blood, urine and feces will collect in five different occasions (baseline, 30 day, 60 day, 90 day, and 120 day) in order to evaluate the prebiotic effect of orange juice on gut microbiota and the bioavailability of its flavanones in blood, urine and feces.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Total counting of aerobic bacteria and facultative anaerobic bacteria
Time Frame: 4 months
|
4 months
|
|
Determination of butyric acid
Time Frame: 4 months
|
4 months
|
|
Determination of acetic acid
Time Frame: 4 months
|
4 months
|
|
Ammonium concentration
Time Frame: 4 mounths
|
4 mounths
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Bioavailability of hesperitin and naringenin in the blood, urine and feces
Time Frame: 4 months
|
Quantification of hesperidin and naringenin and identification and quantification of their metabolites in the blood, urine and feces
|
4 months
|
|
Body mass index
Time Frame: 4 months
|
4 months
|
|
|
Body lean mass
Time Frame: 4 months
|
4 months
|
|
|
Body fat mass
Time Frame: 4 months
|
4 months
|
|
|
% body fat
Time Frame: 4 months
|
4 months
|
|
|
Ratio waist/hip
Time Frame: 4 mounths
|
4 mounths
|
|
|
Glucose
Time Frame: 4 mounths
|
4 mounths
|
|
|
Insulin
Time Frame: 4 mounths
|
4 mounths
|
|
|
Total cholesterol
Time Frame: 4 mounths
|
4 mounths
|
|
|
Low density lipoprotein cholesterol
Time Frame: 4 mounths
|
4 mounths
|
|
|
High density lipoprotein cholesterol
Time Frame: 4 mounths
|
4 mounths
|
|
|
Triglycerides
Time Frame: 4 mounths
|
4 mounths
|
|
|
hsCRP
Time Frame: 4 mounths
|
4 mounths
|
|
|
Alkaline phosphatase
Time Frame: 4 mounths
|
4 mounths
|
|
|
Aspartate enzyme aminotransferase
Time Frame: 4 mounths
|
4 mounths
|
|
|
Alanine enzyme aminotransferase
Time Frame: 4 mounths
|
4 mounths
|
|
|
GammaGT
Time Frame: 4 mounths
|
4 mounths
|
|
|
Glycemic curve
Time Frame: 4 mounths
|
4 mounths
|
|
|
Insulin curve
Time Frame: 4 mounths
|
4 mounths
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Thais B Cesar, PhD, São Paulo State University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253.
- Silveira JQ, Cesar TB, Manthey JA, Baldwin EA, Bai J, Raithore S. Pharmacokinetics of flavanone glycosides after ingestion of single doses of fresh-squeezed orange juice versus commercially processed orange juice in healthy humans. J Agric Food Chem. 2014 Dec 31;62(52):12576-84. doi: 10.1021/jf5038163. Epub 2014 Dec 15.
- Kanaze FI, Bounartzi MI, Georgarakis M, Niopas I. Pharmacokinetics of the citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects. Eur J Clin Nutr. 2007 Apr;61(4):472-7. doi: 10.1038/sj.ejcn.1602543. Epub 2006 Oct 18.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2016
Primary Completion (Actual)
October 1, 2016
Study Completion (Actual)
February 1, 2017
Study Registration Dates
First Submitted
January 6, 2017
First Submitted That Met QC Criteria
January 24, 2017
First Posted (Estimate)
January 26, 2017
Study Record Updates
Last Update Posted (Actual)
April 26, 2017
Last Update Submitted That Met QC Criteria
April 25, 2017
Last Verified
April 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SaoPSU2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
There is still no decision regarding if the individual participant data (IPD) will be available to other researchers.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intestinal Diseases
-
Alfasigma S.p.A.CompletedChronic Intestinal Pseudo-obstructionBelgium, Italy, Spain
-
International University of Health and WelfareNot yet recruitingChronic Intestinal Pseudo-obstructionJapan
-
University of NottinghamNorthern Care Alliance NHS Foundation Trust; Cambridge University Hospitals... and other collaboratorsRecruiting
-
Maastricht University Medical CenterCatharina Ziekenhuis EindhovenCompleted
-
Sohag UniversityRecruitingIntestinal Parasites in Patients With Intestinal CancerEgypt
-
Jinling Hospital, ChinaCompletedChronic Intestinal Pseudo ObstructionChina
-
MovetisCompletedChronic Intestinal Pseudo-ObstructionUnited Kingdom
-
University Hospital, GrenobleRecruiting
-
Assistance Publique - Hôpitaux de ParisCRB-SAT BARM APHP.SU; CRSA UMRS 938RecruitingGastro-Intestinal DisorderFrance
-
Tallaght University HospitalRoyal College of Surgeons, IrelandRecruitingGastro-Intestinal DisorderIreland
Clinical Trials on Orange juice
-
María-Teresa García-ConesaUniversidad Católica San Antonio de MurciaCompleted
-
PepsiCo Global R&DCompletedDigestive HealthUnited States
-
PepsiCo Global R&DCompletedGlycemic ResponseUnited States
-
Loma Linda UniversityCompletedBlood PressureUnited States
-
University of ReadingCompleted
-
Quadram Institute BioscienceBiotechnology and Biological Sciences Research Council; European CommissionCompleted
-
Hasselt UniversityHochschule Geisenheim UniversityCompleted
-
TNOCompletedInflammation | Alcohol ConsumptionNetherlands
-
Rutgers, The State University of New JerseyCompleted
-
University of HohenheimCompleted